Differentiating Chronic Kidney Disease from Acute Renal Failure

Chronic kidney disease (CKD) and acute renal failure (ARF) can both result in elevated creatinine levels, but other factors can help differentiate between the two conditions. In the case of a patient with hypocalcaemia, hyperphosphataemia, and an elevation of parathyroid hormone, CKD is more likely than ARF. These metabolic changes are commonly seen in CKD 4-5 and are not typically present in ARF of short duration. Additionally, the relatively higher creatinine result compared to urea suggests CKD rather than ARF, which can be caused by dehydration and result in even higher urea levels.

This patient likely has CKD and may already be dependent on dialysis or under regular review by a nephrology team. The decision to start dialysis is based on various factors, including fluid overload, hyperkalaemia, uraemic symptoms, life expectancy, and patient/clinician preference. Most patients begin dialysis with an eGFR of around 10 ml/min/1.73m2.

Renal Calculi: Causes and Symptoms

Renal calculi, commonly known as kidney stones, can be caused by various factors such as reduced urine output, changes in medication, and diet. These factors can lead to the formation of stones in the urinary tract, which can cause inflammation and damage to the lining of the urinary tract. Patients with renal calculi may experience symptoms such as blood in their urine due to the damage caused by the stones. Additionally, ketones may be present in the urine, indicating reduced oral intake due to severe pain.

In summary, renal calculi can be caused by various factors and can lead to symptoms such as blood in the urine and reduced oral intake. It is important for patients to seek medical attention if they suspect they may have renal calculi to receive proper diagnosis and treatment.

Primary Hyperparathyroidism and its Complications

Primary hyperparathyroidism is a condition where the parathyroid glands produce too much parathyroid hormone (PTH), leading to elevated calcium levels and low serum phosphate. This condition can go undiagnosed for years, with an incidental finding of elevated calcium often being the first clue. However, complications can arise from longstanding primary hyperparathyroidism, including osteoporosis, renal calculi, and renal calcification.

Osteoporosis occurs due to increased bone resorption under the influence of high levels of PTH. Renal calculi are also a common complication, as high levels of phosphate excretion and calcium availability can lead to the development of calcium phosphate renal stones. Additionally, calcium deposition in the renal parenchyma can cause renal impairment, which can develop gradually over time.

Patients with longstanding primary hyperparathyroidism are at risk of impaired renal function, which is less common in patients with chronic kidney disease of other causes. While both conditions may have elevated PTH levels, hypocalcaemia is more common in chronic kidney disease due to impaired hydroxylation of vitamin D. the complications of primary hyperparathyroidism is crucial for early diagnosis and management of this condition.

Investigating Proteinuria in Diabetic Patients

Proteinuria or microalbuminuria is a significant finding in diabetic patients. It indicates an increased risk of developing diabetic nephropathy in type 1 diabetes and an additional risk factor for cardiovascular disease in type 2 diabetes. When a diabetic patient presents with proteinuria, it is crucial to rule out infection, which is a common cause of increased urinary protein excretion. A urine microbiology test can identify the presence of infection, while an albumin-to-creatinine ratio (ACR) can quantify the degree of proteinuria and allow for future monitoring. Although HbA1c, serum urea/creatinine, and plasma glucose are standard tests for monitoring diabetic patients, they do not help quantify urinary protein loss or exclude infection. A high HbA1c in this situation could indicate longstanding poor glycemic control or poor glycemic control for several weeks due to infection. Therefore, ACR and urine microbiology are the most useful investigations to investigate proteinuria in diabetic patients.

Pathological Processes in Renal Transplant Patients

Double contouring of the glomerular capillary basement membrane is a characteristic feature of transplant glomerulopathy, a chronic antibody-mediated rejection that affects up to 15% of renal transplant patients at five years post-transplant. Acute cellular rejection, on the other hand, is characterized by interstitial inflammation, tubulitis, and/or arthritis, and is unlikely to occur in patients on stable medication doses. Acute humoral rejection, which is characterized by C4d deposition, capillaritis, and/or arthritis, is another possible pathological process in renal transplant patients.

BK viral nephropathy, which occurs in 1-8% of renal transplant patients, is associated with T cell depleting agents such as ATG. Biopsy findings in BK viral nephropathy typically show nuclear viral inclusions in the tubular epithelial cells, which can be limited to the medulla in early disease, and tubulointerstitial inflammation. Urine cytology can also be used to detect decoy cells and urothelial cells with characteristic nuclear viral inclusions, thus avoiding the need for biopsy.

Finally, acute calcineurin inhibitor (CNI) toxicity is unlikely in patients on stable doses of tacrolimus, but almost all patients develop chronic CNI nephrotoxicity. Biopsy findings in chronic CNI nephrotoxicity typically show interstitial fibrosis, tubular atrophy, and arteriolar hyalinosis. In the case of this patient, some background CNI toxicity is likely, but the biopsy findings are more consistent with transplant glomerulopathy as the primary pathological process.

Rhabdomyolysis and Myoglobinuria

Rhabdomyolysis is a common condition that occurs after extreme physical exertion, such as running a marathon. It is characterized by the breakdown of muscle tissue, which releases myoglobin into the bloodstream. Myoglobin is a small molecule that is normally found in muscle cells, but when released into the circulation, it can cause urine to turn a dark color.

There are several causes of rhabdomyolysis and myoglobinuria, including trauma, compartment syndrome, crush injuries, ischemia, severe electrolyte imbalances, bacterial and viral infections, and inherited metabolic disorders like McArdle’s disease. In rare cases, certain drugs like barbiturates and statins can also cause rhabdomyolysis.

It is important to recognize the signs and symptoms of rhabdomyolysis, such as muscle pain, weakness, and dark urine, as it can lead to serious complications like kidney failure if left untreated. Treatment typically involves addressing the underlying cause, such as rehydration and electrolyte replacement, and may require hospitalization in severe cases.

Causes of Haematuria

Haematuria, or blood in the urine, can be caused by various factors. Measles is not one of them. However, conditions such as meatal ulcer and urinary tract infection can lead to haematuria. Additionally, an advanced Wilms’ tumour can also cause this symptom. Another cause of haematuria is Schistosomiasis, which is a parasitic infection caused by Schistosoma haematobium. In this case, the blood in the urine is due to bladder involvement. It is important to identify the underlying cause of haematuria in order to provide appropriate treatment and prevent further complications.

Urinalysis in Pregnancy: Common Abnormalities and Importance of Monitoring

Urinalysis is a crucial diagnostic tool for detecting renal diseases and other medical conditions. During pregnancy, even asymptomatic women may exhibit abnormalities on urinalysis. These abnormalities include small amounts of glucose, increased protein loss associated with pre-eclampsia, and the presence of ketones only during fasting. Pregnant women are also prone to sterile pyuria and non-specific changes in leukocytes.

Monitoring for urinary infections is particularly important during pregnancy, as it has been linked to premature labor. However, minor and non-specific changes on urinalysis can sometimes falsely reassure clinicians. Pregnant women are at a higher risk of UTIs due to their immunosuppressed state, and may present with atypical symptoms or unusual urinalysis features. Therefore, urine should be sent for culture if there are any concerns.

In summary, urinalysis is an essential tool for monitoring the health of pregnant women. the common abnormalities associated with pregnancy and the importance of monitoring for urinary infections can help clinicians provide the best care for their patients.

Proteinuria and its Significance in Patient Assessment

Proteinuria is a condition where protein is present in the urine, which can be an indicator of kidney disease or other underlying health issues. When assessing a patient with suspected proteinuria, it is important to consider their age, activity levels, and the presence of diseases such as diabetes.

Urine albumin levels of 30-300 mg/24 hours are considered microalbuminuria, which is a marker of cardiovascular risk and can predict chronic kidney disease, especially in patients with diabetes. This is usually estimated using the albumin-creatinine ratio (ACR), where an ACR of >3.5 mg/mmol in women or >2.5 mg/mmol in men is considered abnormal. Albuminuria is defined as >300 mg/24 hours or an ACR of >30 mg/mmol.

In some patients, particularly young adults, low-level proteinuria (140 mg – 1 g /24 hours) can be normal and may be caused by factors such as exercise, postural changes, or a high protein diet. However, urine microscopy should be done to exclude casts or cells. Proteinuria levels of 1-2 g/24 hours are more concerning and can be a sign of developing kidney disease such as glomerulonephritis.

If proteinuria levels exceed 3 g/24 hours, it is diagnostic of nephrotic syndrome and requires admission to the hospital for further investigation and management. Some authorities use a cut-off of 3.5 g/24 hours in this case. the significance of proteinuria levels is crucial in patient assessment and can aid in the early detection and management of kidney disease and other underlying health issues.

Overall, proteinuria levels should be carefully monitored and evaluated in the context of the patient’s overall health and medical history.

Renal Artery Stenosis and ACE Inhibitors

This individual with diabetes is experiencing hypertension and arteriopathy, as indicated by mild claudication symptoms and absent pulses in the feet. These factors, combined with macrovascular disease and mild renal impairment, suggest a potential diagnosis of renal artery stenosis (RAS). The introduction of an antihypertensive medication, specifically an ACE inhibitor, resulted in a decline in renal function, further supporting the possibility of RAS. In RAS, hypertension occurs due to the activation of the renin-angiotensin-aldosterone system in an attempt to maintain renal perfusion. However, ACE inhibition can lead to relative renal ischemia, exacerbating the condition. This highlights the importance of considering RAS as a potential cause of hypertension and carefully monitoring the use of ACE inhibitors in individuals with this condition.

The Significance of Urinalysis in Identifying High Levels of Urinary Ketones

Urinalysis is a crucial diagnostic tool that can help identify various renal and non-renal conditions. One of the significant findings in urinalysis is the presence of high levels of urinary ketones. This condition can be observed in patients with diabetic ketoacidosis, which is characterized by high levels of glucose in the body. Additionally, individuals who are experiencing starvation or anorexia nervosa may also exhibit high levels of urinary ketones. Patients with severe illnesses that cause short-term anorexia and those who consume excessive amounts of alcohol may also show this condition.

In summary, urinalysis is a valuable investigation that can help identify high levels of urinary ketones, which can be indicative of various medical conditions. By detecting this condition early on, healthcare professionals can provide prompt and appropriate treatment to prevent further complications.

The Health Benefits and Risks of Being a Kidney Donor

Surprisingly, being a kidney donor can have health benefits. Studies have shown that live donors have lower long-term morbidity and mortality rates than the general population. This is likely due to the rigorous screening process that selects only those with excellent overall health.

While reducing renal mass could potentially lead to a decrease in glomerular filtration rate and an increased risk of end-stage renal failure or hypertension, large-scale studies with up to 35 years of follow-up have shown no increased risk compared to the general population. However, potential donors should be warned about the possibility of end-stage renal failure, particularly those with borderline GFR for donation.

As with any surgery, there are risks involved in kidney donation. The risk of death is quoted at 1 in 3000, and there is a 1-2% risk of major complications such as pneumothorax, injury to other organs, renovascular injury, DVT, or PE. There is also a 20% risk of minor complications such as post-operative atelectasis, pneumonia, wound infection, hematoma, incisional hernia, or urinary tract infection.

To ensure the safety of potential donors, they undergo thorough screening, including a comprehensive medical history, family history, and physical examination. They also undergo extensive investigations of cardiovascular, respiratory, and psychological fitness, as well as multiple tests of renal function and anatomy to determine if it is safe to proceed and select the kidney to be removed.

In conclusion, kidney donation can have health benefits for the donor, but it is not without risks. Only the healthiest individuals are selected as donors, and they undergo rigorous screening to ensure their safety.

Treatment Options for ANCA Vasculitis

ANCA vasculitis is a condition that causes inflammation of blood vessels, leading to organ damage. To treat this condition, induction agents such as cyclophosphamide and rituximab are used in severe or very active cases. Cyclophosphamide is a chemotherapy drug that causes DNA crosslinking, leading to apoptosis of rapidly dividing cells, including lymphocytes. On the other hand, rituximab is a monoclonal antibody that targets CD20, causing profound B cell depletion.

For maintenance or steroid-sparing effects, azathioprine and mycophenolate mofetil are commonly used. However, they take three to four weeks to have their maximal effect, making them unsuitable for severe or very active cases. Ciclosporin, a calcineurin inhibitor, is not widely used in the treatment of ANCA vasculitis, despite its use in transplantation to block IL-2 production and proliferation signals to T cells.

In summary, the treatment options for ANCA vasculitis depend on the severity of the disease. Induction agents such as cyclophosphamide and rituximab are used in severe or very active cases, while maintenance agents like azathioprine and mycophenolate mofetil are used for mild cases. Ciclosporin is not commonly used in the treatment of ANCA vasculitis.

Cardiovascular Risk in Haemodialysis Patients

Haemodialysis patients are at a significantly higher risk of developing cardiovascular disease. Therefore, any sudden deterioration in their condition is a cause for concern. In the case of a previously stable dialysis patient presenting with low blood pressure, excess fluid intake is unlikely to be the cause. Instead, a cardiac event is the most likely explanation.

It is improbable that inadequate haemodialysis is the cause of the patient’s symptoms, as they had a session less than 24 hours ago. Furthermore, if this were the case, the patient would likely have high blood pressure due to fluid accumulation.

While patients on dialysis are more susceptible to infections, the presentation is consistent with acute pulmonary oedema. This condition occurs when fluid accumulates in the lungs, making it difficult to breathe. Therefore, it is essential to monitor haemodialysis patients closely for any signs of cardiovascular disease and promptly address any acute events that may arise.

Factors Affecting Renin and Aldosterone Levels

Renin and aldosterone levels are important in diagnosing primary hyperaldosteronism, but they can be influenced by various factors. Hypervolaemia can cause a decrease in both renin and aldosterone levels, while hypovolaemia can lead to an increase in both. In primary hyperaldosteronism, renin levels decrease while aldosterone levels increase. The use of ACE inhibitors and ARBs can also affect renin and aldosterone levels, causing an increase in renin and a decrease in aldosterone.

In cases where renin and aldosterone levels are abnormal, it is important to consider other factors that may be contributing to the results. For example, hypovolaemia can be caused by diuretic therapy or an intercurrent illness such as gastroenteritis. When hypovolaemia occurs, it stimulates the production of renin and activates the renin-angiotensin-aldosterone system (RAAS), leading to an increase in aldosterone production. Aldosterone then acts to increase sodium and water retention by the kidneys, ultimately increasing intravascular volume.

In summary, the various factors that can affect renin and aldosterone levels is crucial in accurately diagnosing and treating conditions such as primary hyperaldosteronism. Repeat testing may be necessary in cases where other factors, such as hypovolaemia, may be influencing the results.

Donor Evaluation for Organ Transplantation

This patient’s stay in the ICU has been complicated, but the only absolute contraindication to organ donation is malignancy. Although the patient had a limited malignancy without evidence of spread, the risk of cancer in the recipient is too high due to potential micrometastases and immunosuppression. The only other absolute contraindications are HIV or CJD associated illness.

Despite being elderly, a kidney from a relatively healthy 85-year-old donor could be a good match for an elderly recipient in their mid-70s. The patient’s creatinine levels suggest acute tubular necrosis and delayed graft function, but this is likely due to severe sepsis and the patient’s previous normal creatinine levels indicate good baseline renal function. The need for inotropes also suggests acute tubular necrosis, but this is consistent with the patient’s septic shock and acute illness, which could potentially improve after transplantation.

In summary, organ donation evaluation involves considering absolute contraindications such as malignancy, HIV, or CJD associated illness. Age and medical history of the donor and recipient are also important factors to consider. The patient’s current condition and potential for recovery after transplantation should also be taken into account.

Co-trimoxazole and its Side Effects

Co-trimoxazole is a medication that is commonly used to treat and prevent Pneumocystis jiroveci pneumonia, which is more prevalent in immunocompromised individuals. It is a combination of two drugs, trimethoprim and sulfamethoxazole, and is known to cause side effects such as gastrointestinal discomfort, rashes, and hyperkalaemia. Hyperkalaemia is a condition where there is an excess of potassium in the blood, and it is a well-known side effect of co-trimoxazole. This is because the medication inhibits sodium channels in the distal nephron, similar to the potassium-sparing diuretic amiloride.

Although co-trimoxazole is generally safe, it can cause rare but serious side effects such as Stevens-Johnson syndrome, bone marrow depression, and agranulocytosis. Patients who have documented allergies to either component of the medication should avoid it and use pentamidine nebulisers as an alternative. Additionally, co-trimoxazole may be teratogenic, meaning it can cause harm to a developing fetus, so female patients should be advised to use contraception and stop taking the medication if they plan to become pregnant. Overall, co-trimoxazole is an effective medication for treating and preventing Pneumocystis jiroveci pneumonia, but patients should be aware of its potential side effects.

Nephrotic Syndrome

Nephrotic syndrome is a condition characterized by excessive protein loss in the urine, low levels of serum albumin, and peripheral edema. Patients with this condition often have severe hyperlipidemia, with total cholesterol levels exceeding 10 mmol/L. Additionally, the loss of natural anticoagulants in the urine can lead to altered clotting, which requires treatment with antiplatelet agents and/or low molecular weight heparin.

It is important to note that in the early stages of nephrotic syndrome, the levels of urea and creatinine may appear normal despite underlying renal pathology. Therefore, it is crucial to monitor patients with marked hyperlipidemia and proteinuria on urinalysis for signs of nephrotic syndrome. If diagnosed, patients should be referred to a local renal team for management.

Creatinine and Calcium Homeostasis in CKD 3 Patients

In patients with CKD 3, elevated creatinine levels indicate a decline in kidney function. However, interpreting creatinine levels can be challenging without considering factors such as body habitus and muscle mass. To determine the severity of CKD 3, an eGFR calculation can be performed, which typically results in a value of 30-59 ml/min/1.73m2.

Patients with CKD 3 may experience multiple abnormalities in calcium homeostasis. While plasma concentrations of calcium and phosphate are usually normal at this stage, subtle changes may occur as CKD3 progresses towards CKD 4. For example, reduced hydroxylation of vitamin D by the kidney enzyme 1-alpha hydroxylase can lead to a slight increase in PTH levels.

Vitamin D insufficiency is common in CKD3 patients and can be caused by various risk factors such as old age, immobility, institutionalization, and darker skin color. While suboptimal levels of vitamin D may contribute to calcium homeostasis abnormalities, it is not the only factor to consider in CKD3 management.

Nephritic Syndrome and its Underlying Conditions

Nephritic syndrome is a medical condition characterized by blood in the urine, which is likely to be of renal origin. However, it is not a diagnosis in itself and can occur with various underlying renal conditions. The main differential diagnosis for nephritic syndrome is renal stones, which are usually associated with pain.

The underlying conditions that can cause nephritic syndrome include many types of glomerulonephritis, haemolytic uraemic syndrome, Henoch-Schönlein purpura, Goodpasture syndrome, infective endocarditis, systemic lupus erythematosus (SLE) or lupus nephritis, vasculitis, and viral diseases such as hepatitis B or C, EBV, measles, and mumps.

When diagnosing nephritic syndrome, urinalysis is crucial as it will show abundant haemoglobin. However, it is important to note that this can sometimes lead to false positives for bilirubin and urobilinogen, which are related substances. the underlying conditions that can cause nephritic syndrome is essential for proper diagnosis and treatment.

Urinalysis Findings in Urinary Tract Infection

Urinary tract infection (UTI) is a common condition that can be diagnosed through urinalysis. Nitrites and leucocytes are typically present in large amounts in the urine of patients with UTI. Blood may also be present due to inflammation in the bladder or contamination from menstrual bleeding. In some cases, a small amount of glucose may be detected as the body responds to infection by releasing cortisol and adrenaline, which can increase blood glucose levels. However, the presence of protein on urinalysis is usually based on measurement of albumin only, and bacterial proteins are not typically detected using this method. Overall, urinalysis can provide valuable information for diagnosing and managing UTI.

Acute Tubular Necrosis and Tubulo-Interstitial Nephritis

Acute tubular necrosis (ATN) is a condition that occurs when the kidneys experience prolonged hypotension and poor perfusion, leading to the death of tubular epithelium. This can result in complete anuria, which is the absence of urine output. While a blocked catheter is unlikely, a bladder scan should be performed to rule it out. ATN can also be caused by nephrotoxins and sepsis. The condition usually recovers over a few days to weeks, but if the patient has underlying renal disease, the recovery may be partial, leading to long-term chronic kidney disease (CKD). Therefore, pre-renal failure should be corrected as quickly as possible to prevent irreversible damage.

Tubulo-interstitial nephritis (TIN) is a histological diagnosis that occurs when the tubules and interstitium of the kidney become inflamed due to drugs or infections. This can lead to the release of cytokines and infiltration by acute inflammatory cells, particularly lymphocytes and eosinophils. If the causative agent is removed, TIN can resolve. However, if it persists, tubular atrophy and interstitial fibrosis may occur, leading to end-stage renal failure. Oral steroids can be used to dampen the inflammation and prevent fibrosis, but they need to be started early in the disease course.

In summary, ATN and TIN are two conditions that can cause kidney damage and lead to CKD or end-stage renal failure. While ATN is caused by prolonged hypotension and poor perfusion, TIN is caused by drugs or infections. Early intervention is crucial to prevent irreversible damage and promote recovery.

Differential Diagnosis for Mononeuritis Multiplex

Mononeuritis multiplex is a condition characterized by the inflammation of multiple nerves, resulting in both sensory and motor symptoms. While several conditions can cause this, eGPA is the most likely diagnosis for this patient due to his history of adult onset asthma and significantly raised eosinophil count. The painful loss of function, raised inflammatory markers, and reduced amplitude nerve conduction studies also suggest an inflammatory cause of his neuropathy.

While amyloidosis is a possibility, the patient has no history of a disorder that might predispose to secondary amyloid, and no signs of systemic amyloidosis. B12 deficiency and diabetes mellitus are unlikely causes of mononeuritis multiplex, as they do not typically present with this pattern of neuropathy. Lyme disease is also unlikely, as the patient has no rash or arthritis and no history of tick bite.

In summary, while several conditions can cause mononeuritis multiplex, the patient’s history and test results suggest eGPA as the most likely diagnosis. It is important to consider other possibilities, such as amyloidosis, but the inflammatory nature of the patient’s symptoms points towards eGPA as the primary cause.

Ciclosporin’s Side Effects and Decreased Popularity as a Transplantation Maintenance Therapy

Ciclosporin is a medication that is commonly linked to gingival hypertrophy and hirsutism. These side effects can be unpleasant for patients and may lead to decreased compliance with the medication regimen. Additionally, ciclosporin is not as effective as tacrolimus at inhibiting calcineurin, which is a key factor in preventing transplant rejection. As a result, ciclosporin is becoming less popular as a maintenance therapy for transplantation. Physicians are increasingly turning to other medications that have fewer side effects and are more effective at preventing rejection. While ciclosporin may still be used in some cases, it is no longer considered the first-line treatment for transplantation maintenance therapy.

Acute coronary syndrome is the most common cause of chest pain and shortness of breath in dialysis patients due to their increased risk of coronary disease. Air embolism, hypotension, massive haemolysis, and pulmonary embolism are also possible causes but are less likely. Air embolism is rare but can occur in patients with central lines, while hypotension is more common in the elderly and new starters on dialysis. Massive haemolysis is rare but serious, and pulmonary embolism can occur if there is a known thrombus in the fistula.

Primary Hyperaldosteronism: A Common Cause of Hypertension

Primary hyperaldosteronism is a prevalent cause of hypertension that typically affects individuals between the ages of 20 and 40. However, it is often asymptomatic in its early stages and may not be diagnosed until several decades later. This condition may account for approximately 10% of hypertension cases and is characterized by hypokalemia, metabolic alkalosis, onset of hypertension at a young age, and hypertension that is difficult to control with more than three medications.

The primary cause of primary hyperaldosteronism is either adrenal adenoma or adrenal hyperplasia, which preferentially affects the zona glomerulosa. Adrenal adenomas are usually unilateral, but bilateral adenomas can occur in a minority of cases. On the other hand, adrenal hyperplasia typically causes bilateral disease. Despite the decreased occurrence of hypokalemia and metabolic alkalosis in primary hyperaldosteronism, it remains a significant contributor to hypertension and should be considered in patients with uncontrolled hypertension.

Recommended Treatment for a Patient with CKD Stage 5

Of the drugs listed, erythropoietin is the most appropriate for a patient with chronic kidney disease (CKD) stage 5 who is experiencing fatigue and shortness of breath due to low hemoglobin levels. However, it is important to check the patient’s haematinics to ensure that iron, B12, or folate supplementation would not be more beneficial. Alfacalcidol is typically used to treat hyperparathyroidism, but it is not necessary for CKD stage 5 patients until their parathyroid hormone levels rise above 28 pmol/L, according to the Renal Association Guidelines. Since the patient’s bicarbonate levels are normal, oral supplementation is not required. Calcichew D3 and sevelamer are phosphate binders that prevent hyperphosphataemia, but they are not necessary for this patient. For further information, refer to the Renal Association Clinical Practice Guidelines.

Patients with end stage kidney disease have poor iron absorption and lack endogenous erythropoietin, making parenteral iron replacement and erythropoietin the best management. Anaemia is common in these patients due to poor oral iron absorption and GI blood loss. Acute packed red cell transfusion is extreme and renal transplant may be an option, but the patient’s haemoglobin can be modified with increased IV iron and epo doses. Oral iron tablets are poorly absorbed and tolerated.

Myeloma Diagnosis in Patient C

Patient C has been diagnosed with myeloma, a type of cancer that affects the plasma cells in the bone marrow. This diagnosis is supported by several indicators, including elevated total protein levels with low albumin and abnormally high globulins. Additionally, the patient has high serum calcium levels and suppressed parathyroid hormone, which are consistent with hypercalcaemia of malignancy. High phosphate levels are also present, which is a common occurrence in haematological malignancies where there is a large amount of cell turnover.

Furthermore, the patient is experiencing renal impairment, which is typically caused by chronic kidney deterioration due to the deposition of myeloma casts in the nephrons. However, the hypercalcaemia can also cause dehydration, exacerbating the renal impairment. Overall, these indicators point towards a diagnosis of myeloma in Patient C.

Glomerular Proteinuria and Minimal Change Disease

Glomerular proteinuria is a condition characterized by the presence of protein in the urine due to damage to the glomeruli, the tiny filters in the kidneys responsible for removing waste from the blood. This condition can be caused by primary glomerular disease, glomerulonephritis, anti-GBM disease, immune complex deposition, and inherited conditions such as Alport’s syndrome. Additionally, secondary glomerular disease can result from systemic diseases like diabetes.

One type of glomerulonephritis that is particularly common in children is minimal change disease. This condition has a good prognosis and can often be treated effectively with steroids. It is important to promptly diagnose and treat glomerular proteinuria to prevent further damage to the kidneys and maintain overall kidney function.